---
/**
 * Thesis Section 13: M&A Path
 * Big pharma acquisition path with inline citations
 */
import InlineCitation from '@components/citations/InlineCitation.astro';

interface Props {
  id?: string;
}

const { id = 'ma-path' } = Astro.props;

// Citation data for M&A path statistics
const citations = {
  spherical: { index: 1, hexCode: 's0d2yp', title: 'Top 10 Global Companies in Anti-aging Therapeutics Market 2025', url: 'https://www.sphericalinsights.com/blogs/top-10-global-companies-in-anti-aging-therapeutics-market-2025-strategic-overview-future-trends-2024-2035', source: 'Spherical Insights', publishedDate: '2025-08-19' },
  wellington: { index: 2, hexCode: 'ct5ss8', title: 'Biotech IPOs in 2025', url: 'https://www.wellington.com/en/insights/biotech-ipos-in-2025', source: 'Wellington Management', publishedDate: '2024-08-22' },
  labiotech: { index: 3, hexCode: '4729z2', title: '13 anti-aging biotech companies leading longevity in 2025', url: 'https://www.labiotech.eu/best-biotech/anti-aging-biotech-companies/', source: 'Labiotech', publishedDate: '2025-10-27' },
  patentpc: { index: 4, hexCode: 'kh56wu', title: 'Longevity Biotech Market Growth: How Fast Is Anti-Aging Science Advancing', url: 'https://patentpc.com/blog/longevity-biotech-market-growth-how-fast-is-anti-aging-science-advancing-new-stats', source: 'PatentPC', publishedDate: '2025-11-14' },
};
---

<section class="slide slide-ma" id={id}>
  <div class="slide-gradient slide-gradient-shift"></div>
  <div class="slide-content">
    <h2 class="section-title reveal-item" data-reveal="fade-up" style="--delay: 0ms;">üè¢ Acquisitions by Big Pharma</h2>
    <p class="section-body reveal-item" data-reveal="fade-up" style="--delay: 100ms;">
      Large pharma companies facing patent cliffs are increasingly acquiring
      longevity-adjacent assets to sustain growth.
    </p>
    <div class="path-points">
      <div class="path-point reveal-item" data-reveal="fade-up" style="--delay: 200ms;">
        <h4>Massive Market Growth</h4>
        <p>Global anti-aging therapeutics projected to grow from $5.7B (2024) to $34.6B by 2035.<InlineCitation {...citations.spherical} /></p>
      </div>
      <div class="path-point reveal-item" data-reveal="fade-up" style="--delay: 300ms;">
        <h4>M&A as Core Return Driver</h4>
        <p>Institutional investors expect continued M&A as pharma uses acquisitions to access innovative platforms.<InlineCitation {...citations.wellington} /></p>
      </div>
      <div class="path-point reveal-item" data-reveal="fade-up" style="--delay: 400ms;">
        <h4>Strategic Fit</h4>
        <p>Longevity mechanisms intersect with existing pharma markets‚Äîcardiometabolic, oncology, ophthalmology.<InlineCitation {...citations.labiotech} /></p>
      </div>
      <div class="path-point reveal-item" data-reveal="fade-up" style="--delay: 500ms;">
        <h4>VC Capital Precursor</h4>
        <p>Longevity VC funds raised over $3B in 2023, seeding future acquisition targets.<InlineCitation {...citations.patentpc} /></p>
      </div>
    </div>
  </div>
</section>

<style>
  .path-points {
    display: grid;
    grid-template-columns: repeat(2, 1fr);
    gap: 1.5rem;
  }

  @media (max-width: 768px) {
    .path-points {
      grid-template-columns: 1fr;
    }
  }

  .path-point {
    padding: 1.5rem;
    border-radius: 1rem;
  }

  .path-point h4 {
    font-size: 1rem;
    font-weight: 600;
    margin-bottom: 0.5rem;
  }

  .path-point p {
    font-size: 0.875rem;
    line-height: 1.5;
  }

  :global([data-mode="dark"]) .path-point {
    background: rgba(15, 9, 35, 0.8);
    border: 1px solid rgba(108, 99, 255, 0.15);
  }

  :global([data-mode="dark"]) .path-point h4 {
    color: var(--color-alabaster);
  }

  :global([data-mode="dark"]) .path-point p {
    color: rgba(249, 250, 251, 0.6);
  }
</style>
